Next generation sequencing based in-house HIV genotyping method: validation report

Autor:	Isaac Ssewanyana, Alisen Ayitewala, Charles Kiyaga
Jazyk:	angličtina
Rok vydání:	2021
Předmět:	Genotype Human immunodeficiency virus (HIV) Next Generation Sequencing HIV Infections Drug resistance Computational biology medicine.disease_cause DNA sequencing symbols.namesake Acquired immunodeficiency syndrome (AIDS) Virology Drug Resistance Viral Medicine Humans Pharmacology (medical) Viral rna Uganda HIV Genotyping Genotyping Sanger sequencing business.industry Methodology High-Throughput Nucleotide Sequencing Amplicon RC581-607 medicine.disease Sanger Sequencing Mutation symbols HIV-1 Molecular Medicine Immunologic diseases. Allergy business
Zdroj:	AIDS Research and Therapy, Vol 18, Iss 1, Pp 1-9 (2021) AIDS Research and Therapy
ISSN:	1742-6405
Popis:	Background HIV genotyping has had a significant impact on the care and treatment of HIV/AIDS. At a clinical level, the test guides physicians on the choice of treatment regimens. At the surveillance level, it informs policy on consolidated treatment guidelines and microbial resistance control strategies. Until recently, the conventional test has utilized the Sanger sequencing (SS) method. Unlike Next Generation Sequencing (NGS), SS is limited by low data throughput and the inability of detecting low abundant drug-resistant variants. NGS can improve sensitivity and quantitatively identify low-abundance variants; in addition, it has the potential to improve efficiency as well as lowering costs when samples are batched. Despite the NGS benefits, its utilization in clinical drug resistance profiling is faced with mixed reactions. These are largely based on a lack of a consensus regarding the quality control strategy. Nonetheless, transitional views suggest validating the method against the gold-standard SS. Therefore, we present a validation report of an NGS-based in-house HIV genotyping method against the SS method in Uganda. Results Since there were no established proficiency test panels for NGS-based HIV genotyping, 15 clinical plasma samples for routine care were utilized. The use of clinical samples allowed for accuracy and precision studies. The workflow involved four main steps; viral RNA extraction, targeted amplicon generation, amplicon sequencing and data analysis. Accuracy of 98% with an average percentage error of 3% was reported for the NGS based assay against the SS platform demonstrating similar performance. The coefficient of variation (CV) findings for both the inter-run and inter-personnel precision showed no variability (CV ≤ 0%) at the relative abundance of ≥ 20%. For both inter-run and inter-personnel, a variation that affected the precision was observed at 1% frequency. Overall, for all the frequencies, CV registered a small range of (0–2%). Conclusion The NGS-based in-house HIV genotyping method fulfilled the minimum requirements that support its utilization for drug resistance profiling in a clinical setting of a low-income country. For more inclusive quality control studies, well-characterized wet panels need to be established.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed1c3aa33a44674002b103f3f7804eec https://doaj.org/article/e0f0fd7107c043c8b7136c3e579527dd Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.